These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 611666)

  • 1. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
    Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH
    Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pituitary hormones in the growth of human breast cancer.
    Pearson OH; Manni A; Chambers M; Brodkey J; Marshall JS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4323-6. PubMed ID: 212192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihormone treatment of stage IV breast cancer.
    Manni A; Trujillo JE; Marshall JS; Brodkey J; Pearson OH
    Cancer; 1979 Feb; 43(2):444-50. PubMed ID: 421171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function.
    Manni A; Pearson OH
    Cancer Treat Rep; 1980; 64(6-7):779-85. PubMed ID: 6775808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer.
    Manni A; Arafah BM; Pearson OH
    Cancer; 1981 Dec; 48(11):2507-9. PubMed ID: 7296499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophysectomy for metastatic cancer.
    Ray BS
    J Med Liban; 1972; 25(5):393-400. PubMed ID: 4669960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
    Sawka CA; Pritchard KI; Paterson AH; Sutherland DJ; Thomson DB; Shelley WE; Myers RE; Mobbs BG; Malkin A; Meakin JW
    Cancer Res; 1986 Jun; 46(6):3152-6. PubMed ID: 3084082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrinologically incomplete transethmoidal trans-sphenoidal hypophysectomy with relief of bone pain in breast cancer.
    LaRossa JT; Strong MS; Melby JC
    N Engl J Med; 1978 Jun; 298(24):1332-5. PubMed ID: 651992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsphenoidal hypophysectomy in breast cancer: evidence for an individual role of pituitary and gonadal hormones in supporting tumor growth.
    Manni A; Pearson OH; Brodkey J; Marshall JS
    Cancer; 1979 Dec; 44(6):2330-7. PubMed ID: 509401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
    Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.